November 2015 Life Science Industry Research Reports

Skin Infections Global Clinical Trials Review, H2, 2015

Published in Nov 2015 ; US $ 2500 Onwards; Publisher: GlobalData

Skin Infections Global Clinical Trials Review, H2, 2015 Summary GlobalData’s clinical trial report, “Skin Infections Global Clinical Trials Review, H2, 2015” provides an overview of Skin Infections clinical trials scenario. This report provides top line data relating to the clinical […]

Iron Poisoning Global Clinical Trials Review, H2, 2015

Published in Nov 2015 ; US $ 2500 Onwards; Publisher: GlobalData

Iron Poisoning Global Clinical Trials Review, H2, 2015 Summary GlobalData’s clinical trial report, “Iron Poisoning Global Clinical Trials Review, H2, 2015” provides an overview of Iron Poisoning clinical trials scenario. This report provides top line data relating to the clinical […]

Spinocerebellar Ataxias Global Clinical Trials Review, H2, 2015

Published in Nov 2015 ; US $ 2500 Onwards; Publisher: GlobalData

Spinocerebellar Ataxias Global Clinical Trials Review, H2, 2015 Summary GlobalData’s clinical trial report, “Spinocerebellar Ataxias Global Clinical Trials Review, H2, 2015” provides an overview of Spinocerebellar Ataxias clinical trials scenario. This report provides top line data relating to the clinical […]

Eczema Global Clinical Trials Review, H2, 2015

Published in Nov 2015 ; US $ 2500 Onwards; Publisher: GlobalData

Eczema Global Clinical Trials Review, H2, 2015 Summary GlobalData’s clinical trial report, “Eczema Global Clinical Trials Review, H2, 2015” provides an overview of Eczema clinical trials scenario. This report provides top line data relating to the clinical trials on Eczema. […]

Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H2 2015

Published in Nov 2015 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H2 2015′, provides an overview of the Relapsing Multiple Sclerosis (RMS)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Relapsing Multiple Sclerosis (RMS), complete with comparative […]